Research Article

The Role of Parathyroid Hormone and Vitamin D Serum Concentrations in Patients with Cardiovascular Diseases

Table 1

Patient characteristic divided depending on heart failure occurrence.

HF present ()HF absent ()

Age61.5 (57.0–74.0)65.3 (57.0–74.0)ns
Male (%)36 (72)43 (56)ns
BMI28.1 (24.3–30.9)28.5 (25.4–31.2)ns
Hypertension38 (76)61 (79)ns
Dyslipidemia32 (64)38 (49)ns
Diabetes15 (30)27 (35)ns
Atrial fibrillation14 (28)8 (10)0.02
Urgent admission22 (44)34 (44)ns
Sun exposure >7 h/week26 (52)50 (65)ns
Coronary artery disease39 (78)59 (77)ns
EDV (ml)146.2 ± 55.986.3 ± 20.90.001
LVEF (%)28.7 ± 11.755.9 ± 4.70.001
ICD12 (24)1 (1)0.001
CRT2 (4)0 (0)ns
DDDR2 (4)13 (17)0.06
VVIR2 (4)5 (5)ns
OHT2 (4)0 (0)ns
DEATH (during hospitalization)2 (4)2 (3)ns

HF: heart failure; BMI: body mass index; >7 h/week: more than seven hours per week; EDV: end-diastolic volume; LVEF: left ventricular ejection fraction; ICD: implantable cardioverter-defibrillator; CRT: cardiac resynchronization therapy; DDDR: dual chamber permanent pacemaker; VVIR: single chamber permanent pacemaker; OHT: orthotopic heart transplantation.